Anthracyclines in the Treatment of Early Breast Cancer
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 45 (2) , 1-3
- https://doi.org/10.2165/00003495-199300452-00002
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Canadian Experience with Intensive Fluorouracil, Epirubicin and Cyclophosphamide in Patients with Early Stage Breast CancerDrugs, 1993
- Present Status of Anthracyclines in the Adjuvant Treatment of Breast CancerDrugs, 1993
- Anthracyclines in the Adjuvant Treatment of Breast CancerDrugs, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.1992
- Systemic Therapy of Advanced Breast CancerDrugs, 1992
- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.Journal of Clinical Oncology, 1990
- Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid TumoursActa Oncologica, 1990
- A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B studyAmerican Journal of Clinical Oncology, 1984
- Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trialCancer, 1978